Interspecific co-transfer of antibiotic resistance plasmids in staphylococci in vivo.

by Naidoo, J.
Published 1984

Smoking cessation programmes targeted at black and minority ethnic communities.

by Farren, C., Naidoo, J.
Published 1996

Acquisition of antibiotic resistance by Staphylococcus aureus in skin patients.

by Naidoo, J, Noble, W C
Published 1978

Transfer of gentamicin resistance between coagulase-negative and coagulase-positive staphylococci on skin.

by Naidoo, J., Noble, W. C.
Published 1981

Some effects of plasmids coding for antibiotic resistance on the virulence of Staphylococcus aureus.

by Kinsman, O. S., Naidoo, J., Noble, W. C.
Published 1985

Immune modulation for cancer therapy

by Naidoo, J, Page, D B, Wolchok, J D
Published in Br J Cancer (2014)

Gentamicin-resistant staphylococci: genetics of an outbreak in a dermatology department.

by Naidoo, J., Noble, W. C., Weissmann, A., Dyke, K. G.
Published 1983

Methicillin-resistant Staphylococcus aureus: a 6-month survey in a Lisbon paediatric hospital.

by Melo Cristino, J. A., Pereira, A. T., Afonso, F., Naidoo, J. N.
Published 1986

A community outbreak of group A beta haemolytic streptococci with transferable resistance to erythromycin.

by Scott, R. J., Naidoo, J., Lightfoot, N. F., George, R. C.
Published 1989

Differences in survival of patients with recurrent versus de novo metastatic KRAS and EGFR mutant lung cancers

by Yu, H. A., Sima, C. S., Hellmann, M. D., Naidoo, J., Busby, N., Rodriguez, K., Riely, G. J., Kris, M. G.
Published in Cancer (2015)

EGFR exon 20 insertions in advanced lung adenocarcinomas: clinical outcomes and response to erlotinib

by Naidoo, J, Sima, CS, Rodriguez, K, Busby, N, Nafa, K, Ladanyi, M, Riely, GJ, Kris, MG, Arcila, ME, Yu, HA
Published in Cancer (2015)

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

by Naidoo, J., Page, D. B., Li, B. T., Connell, L. C., Schindler, K., Lacouture, M. E., Postow, M. A., Wolchok, J. D.
Published in Ann Oncol (2016)

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

by Naidoo, J., Page, D. B., Li, B. T., Connell, L. C., Schindler, K., Lacouture, M. E., Postow, M. A., Wolchok, J. D.
Published in Ann Oncol (2015)

High-level vancomycin-resistant enterococci causing hospital infections.

by Uttley, A. H., George, R. C., Naidoo, J., Woodford, N., Johnson, A. P., Collins, C. H., Morrison, D., Gilfillan, A. J., Fitch, L. E., Heptonstall, J.
Published 1989

The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis

by Walker, AK, Rivera, PD, Wang, Q, Chuang, J-C, Tran, S, Osborne-Lawrence, S, Estill, SJ, Starwalt, R, Huntington, P, Morlock, L, Naidoo, J, Williams, NS, Ready, JM, Eisch, AJ, Pieper, AA, Zigman, JM
Published 2014

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%

by Gainor, J. F., Rizvi, H., Aguilar, E. Jimenez, Skoulidis, F., Yeap, B. Y., Naidoo, J., Khosrowjerdi, S., Mooradian, M., Lydon, C., Illei, P., Zhang, J., Peterson, R., Ricciuti, B., Nishino, M., Zhang, J., Roth, J. A., Grishman, J., Anderson, D., Little, B. P., Carter, B. W., Arbour, K., Sauter, J. L., Mino-Kenudson, M., Heymach, J. V., Digumarthy, S., Shaw, A. T., Awad, M. M., Hellmann, M. D.
Published in Ann Oncol (2019)

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

by Forde, P.M., Chaft, J.E., Smith, K.N., Anagnostou, V., Cottrell, T.R., Hellmann, M.D., Zahurak, M., Yang, S.C., Jones, D.R., Broderick, S., Battafarano, R.J., Velez, M.J., Rekhtman, N., Olah, Z., Naidoo, J., Marrone, K.A., Verde, F., Guo, H., Zhang, J., Caushi, J.X., Chan, H.Y., Sidhom, J.-W., Scharpf, R.B., White, J., Gabrielson, E., Wang, H., Rosner, G.L., Rusch, V., Wolchok, J.D., Merghoub, T., Taube, J.M., Velculescu, V.E., Topalian, S.L., Brahmer, J.R., Pardoll, D.M.
Published in N Engl J Med (2018)